Építés alatt – nem éles oldal
Belépés
Visszavonva2. fázis

Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury

A legfontosabb adatok

Ki végzi
University of Pennsylvania
Hol
Philadelphia (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Visszavonva
Fázis
2. fázis
Kezdés
2017. jan.
Befejezés
2023. dec.
A vizsgálat típusa
Beavatkozással járó, 4 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
A vizsgált kezelések
  • Omega 3 fatty acid
  • Safflower seed oil
A regiszteradat frissítve
2022. október 13.
Miért állt le
Unable to recruit participants

Ki vehet részt

Életkor
18 év – 55 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 27 feltétel megnézéseKevesebb

Ki vehet részt

  • Age 18-55
  • Documented/ verified TBI
  • Ability to swallow study agent within 48h of injury
  • If a sexually active female who is able to get pregnant, must be already taking birth control (prescription contraception)
  • Visual acuity/ hearing adequate for testing
  • Fluency in English or Spanish
  • Ability to provide informed consent for themselves
  • Co-enrolled in PARC-TBI protocol (IRB protocol #825783) or TRACK-TBI (IRB protocol #825503)
  • GCS 13-15

Ki nem vehet részt

  • History of pre-existing neurologic disorder, such as dementia, uncontrolled epilepsy, multiple sclerosis, strokes, brain tumors, prior severe TBI, or other disorder that confounds interpretation neuropsychological results
  • Consumption of fish or seafood 3 or more times per week on average or regular administration of omega-3 supplements (e.g., cod liver oil, borage oil, fish oil or evening primrose oil) defined as an average of 250 mg/day of n-3 HUFAs, over the previous 3 months
  • Use of anticoagulant medications or aspirin more than once per week within the last three months
  • Enrollment in any concurrent research protocols that would interfere with participant safety or research data integrity
  • Acute ischemic heart disease or abnormal heart rhythm
  • History of abnormality in liver function
  • History or evidence of active malignancy
  • History of diabetes
  • History of pre-existing disabling Axis I psychiatric disorder, such as major depression, schizophrenia, bipolar disorder or dementia
  • Allergy to omega-3 fatty acid ethyl esters or any ingredient of the study agent
  • Known allergy to Safflower seed oil or ragweed plants
  • Allergy, hypersensitivity, or intolerance to fish oils or omega-3 fats which are found in fish
  • Unstable respiratory or hemodynamic status
  • Evidence of penetrating brain injury
  • Requirement for craniotomy or craniectomy
  • Evidence of serious infectious complications
  • Pregnancy or breast-feeding
  • Prisoners or patients in custody

Helyszínek itt: Egyesült Államok

  • Penn Presbyterian Medical CenterPhiladelphia, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This is a Phase 2 clinical trial designed to obtain data on relationships between potentially therapeutic doses of n-3 HUFA (highly unsaturated fatty acids) and their bioactive molecular derivatives, synaptamide, 17-hydroxy-DHA, and D-series resolvins, on clinical outcomes after TBI.

A vizsgálat 4 csoportja

  • 1,000mg/day n-3 HUFAA vizsgált kezelés

    Subjects will take one capsule daily starting at study enrollment (within 24 hours of injury) for 14 consecutive days.

    Kezelés: Omega 3 fatty acid

  • 4,000 mg/day n-3 HUFAA vizsgált kezelés

    Subjects will take 2 capsules twice daily starting at enrollment (within 24 hours of injury) for 14 consecutive days.

    Kezelés: Omega 3 fatty acid

  • 1 capsule safflower seed oilPlacebo, összehasonlításként

    Subjects will take 1 capsule daily starting at enrollment (within 24 hours of injury) for 14 consecutive days.

    Kezelés: Safflower seed oil

  • 4 capsules safflower seed oilPlacebo, összehasonlításként

    Subjects will take 2 capsules twice daily starting at enrollment (within 24 hours of injury) for 14 consecutive days.

    Kezelés: Safflower seed oil

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Traumatic Brain Injury Recovery With n-3 Highly Unsaturated Fatty Acids (HUFAs): A Biomarker-driven Approach
A regiszteradat frissítve
2022. október 13.